COMMENTS ON: Megadose Methylprednisolone for the Treatment of Patients with Evans Syndrome

ISSN： 1521-0669

Source： Pediatric Hematology and Oncology, Vol.21, Iss.8, 2004-12, pp. : 741-741

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MEGADOSE METHYLPREDNISOLONE FOR EVANS SYNDROME

By Özsoylu Şinasi

Pediatric Hematology and Oncology, Vol. 17, Iss. 8, 2000-12 ,pp. : 725-726

Informa Healthcare

Access to resources Recommend Favorite

MEGADOSE METHYPREDNISOLONE FOR THE TREATMENT OF PATIENTS WITH EVANS SYNDROME

By Özsoylu Fiinasi

Pediatric Hematology and Oncology, Vol. 21, Iss. 8, 2004-12 ,pp. : 739-740

Informa Healthcare

Access to resources Recommend Favorite

TREATMENT OF KASABACH–MERRITT SYNDROME BY MEGADOSE METHYLPREDNISOLONE

By Özsoylu Şinasi

Pediatric Hematology and Oncology, Vol. 19, Iss. 5, 2002-07 ,pp. : 373-374

Informa Healthcare

Access to resources Recommend Favorite

MEGADOSE METHYLPREDNISOLONE FOR KASABACH-MERRITT SYNDROME

By Ozsoylu Sinasi

Pediatric Hematology and Oncology, Vol. 16, Iss. 4, 1999-07 ,pp. : 373-374

Informa Healthcare

Access to resources Recommend Favorite

MEGADOSE METHYLPREDNISOLONE FOR PROMYELOCYTIC LEUKEMIA

By Özsoylu Şinasi

Pediatric Hematology and Oncology, Vol. 17, Iss. 8, 2000-12 ,pp. : 723-723

Informa Healthcare

Access to resources Recommend Favorite